Overview

INNOVA4TB is an international and intersectoral consortium that combines institutions from high and medium/low Tuberculosis (TB) incidence countries, with large experience in clinical managing M/XDR-TB cases; high-level universities and research institutions with experience in complementary basic and translational research focused on TB diagnosis; and small and medium-size enterprises (SMEs) focused on the TB diagnosis, using different novel technological approaches, interested in transferring the research into innovative products, services and/or processes. 🇪🇺 The INNOVA4TB project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 823854.